Literature DB >> 23115490

Using pharmacogenetics to understand adverse drug reactions in children.

Kaitlyn Shaw1, Ursula Amstutz, Bruce C Carleton.   

Abstract

Entities:  

Year:  2011        PMID： 23115490      PMCID： PMC3223886          DOI： 10.1093/pch/16.9.537

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  9 in total

Review 1.  Anticipating clinical integration of pharmacogenetic treatment strategies for addiction: are primary care physicians ready?

Authors:  A E Shields; C Lerman
Journal:  Clin Pharmacol Ther       Date:  2008-03-05       Impact factor: 6.875

Review 2.  Implications of pharmacogenetics for individualizing drug treatment and for study design.

Authors:  Christian Meisel; Thomas Gerloff; Julia Kirchheiner; Przemyslaw M Mrozikiewicz; Przemyslaw Niewinski; Jürgen Brockmöller; Ivar Roots
Journal:  J Mol Med (Berl)       Date:  2003-03-15       Impact factor: 4.599

3.  In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes.

Authors:  Ulrike Nowak-Göttl; Kevin Dietrich; Daria Schaffranek; Noha Sharaf Eldin; Yutaka Yasui; Christof Geisen; Lesley G Mitchell
Journal:  Blood       Date:  2010-09-10       Impact factor: 22.113

Review 4.  Transfer of drugs and other chemicals into human milk.

Authors: 
Journal:  Pediatrics       Date:  2001-09       Impact factor: 7.124

Review 5.  Developmental and pediatric pharmacogenomics.

Authors:  J Steven Leeder
Journal:  Pharmacogenomics       Date:  2003-05       Impact factor: 2.533

6.  Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.

Authors:  Colin J D Ross; Hagit Katzov-Eckert; Marie-Pierre Dubé; Beth Brooks; S Rod Rassekh; Amina Barhdadi; Yassamin Feroz-Zada; Henk Visscher; Andrew M K Brown; Michael J Rieder; Paul C Rogers; Michael S Phillips; Bruce C Carleton; Michael R Hayden
Journal:  Nat Genet       Date:  2009-11-08       Impact factor: 38.330

7.  Adverse drug reaction active surveillance: developing a national network in Canada's children's hospitals.

Authors:  Bc Carleton; Rl Poole; Ma Smith; Js Leeder; R Ghannadan; Cjd Ross; Ms Phillips; Mr Hayden
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-08       Impact factor: 2.890

8.  Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study.

Authors:  P Madadi; C J D Ross; M R Hayden; B C Carleton; A Gaedigk; J S Leeder; G Koren
Journal:  Clin Pharmacol Ther       Date:  2008-08-20       Impact factor: 6.875

9.  Spontaneous adverse drug reaction reporting vs event monitoring: a comparison.

Authors:  A P Fletcher
Journal:  J R Soc Med       Date:  1991-06       Impact factor: 18.000
  9 in total
  1 in total

1.  Physicians' Attitudes and Ethical Obligations to Pharmacogenetic Testing.

Authors:  Suhaib Muflih; Belal A Al-Husein; Reema Karasneh; Karem H Alzoubi
Journal:  J Multidiscip Healthc       Date:  2020-03-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.